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1094 The Journal of Thoracic and CardObjective: Neonates with hypoplastic left heart syndrome have impaired systemic
oxygen delivery and also have a high risk of hypoxic ischemic brain injury with
resultant neurodevelopmental impairment. We hypothesized that decreased postop-
erative oxygen delivery, as measured on the basis of systemic venous oxyhemo-
globin saturation, would be related to persistent neurodevelopmental abnormality
assessed in childhood.
Methods: Early perioperative hemodynamic data, prospectively acquired from ne-
onates undergoing staged palliation of hypoplastic left heart syndrome by using
deep hypothermic circulatory arrest with uniform perioperative management, were
tested for relationship to later neurodevelopmental outcome assessed at age 4 years.
Results: Complete hemodynamic and neurodevelopmental data were available in 13
patients aged 7  8 days at the time of the Norwood procedure and aged 4.5  0.7
years at follow-up assessment. The subjects scored significantly below the popula-
tion mean for motor, visual-motor integration, and composite neurodevelopmental
outcomes. The 5 (38%) patients with abnormal outcomes had significantly lower
postoperative systemic venous oxygen saturation values than those with normal
outcomes (46% 8% vs 56% 6%, P .024). Standard hemodynamic parameters
did not differentiate patient outcomes. The risk of abnormal outcome increased with
increasing time at a systemic venous oxygen saturation of less than 40% (P .001).
A multivariate model of deep hypothermic circulatory arrest time, systemic venous
oxygen saturation, blood pressure, and carbon dioxide tension accounted for 79% of
the observed variance (P  .001).
Conclusions: Decreased systemic oxygen delivery in the neonatal postoperative
period is associated with hypoxic-ischemic brain injury and childhood neurodevel-
opmental abnormality. Measures of systemic oxygen delivery should be used to
guide perioperative strategies to reduce the risk of hypoxic-ischemic brain injury.
Children with congenital heart disease are at increased risk for neurodevel-opmental impairment. Causes of reduced neurodevelopmental outcome in-clude genetic factors, abnormalities of the aortic arch (including hypoplastic
left heart syndrome [HLHS]),1 hypoxic-ischemic injury, genetic predisposition,2
and complex environmental factors.3-5 Perioperative events are commonly identified
as potential causes of hypoxic-ischemic injury,6-8 particularly prolonged periods of
circulatory arrest9 and other cardiopulmonary bypass (CPB) support strategies that
reduce oxygen delivery, such as anemia10 and alkalosis.11,12 However, intraopera-
tive factors do not adequately explain all adverse outcomes.5,8,13-15
We have previously identified a higher risk of reduced systemic oxygen delivery
by using continuous systemic venous oxygen saturation (SvO2) monitoring and
reduced cerebral oxygen saturation by using near-infrared spectroscopy (NIRS) in
the early postoperative period in neonates undergoing the Norwood procedure.15-17
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DPositing that impaired neurodevelopmental outcome might
be a late manifestation of postoperative hypoxic-ischemic
injury, we examined the relationship between neonatal peri-
operative hemodynamics and school-age neurodevelopmen-
tal outcome in survivors of staged palliation of HLHS. The
primary hypothesis was that inadequate postoperative oxy-
gen delivery, assessed by measuring SvO2 after neonatal
stage 1 repair, would be a predictor of poor neurocognitive
function at age 4 years.
Methods
Patients
All neonates undergoing staged palliation of HLHS since 1996
have had neonatal perioperative hemodynamics maintained in a
database. All survivors have been offered enrollment in a neuro-
developmental outcome study after achieving acceptable hemody-
namics for completion of the Fontan procedure and attaining a
minimum age of 3.5 years. Because perioperative management
strategies have evolved over the past decade in ways that might
affect hypoxic-ischemic injury, we limited this analysis to patients
who had undergone a modified Norwood procedure for stage 1
palliation (S1P) of HLHS or a single-ventricle variant with deep
hypothermic circulatory arrest (DHCA) after achievement of syn-
thetic opioid-based perioperative anesthesia, as previously de-
scribed.16,18 Cooling to 18°C to 20°C was achieved with a high-
flow modified pH-stat strategy with a minimum cooling time of 25
minutes,19 followed by a shift to alpha-stat blood gas management
just before circulatory arrest.20 All patients had continuous supe-
rior vena caval (SVC) SvO2 monitoring to guide an aggressive
inodilator strategy with an SvO2 target of 50%.16,18,21
Of 43 sequential patients who had S1P performed from 1996
through 1999 by using this standardized perioperative manage-
ment strategy, 30 were alive at the time of this cross-sectional
study. Three were excluded because of coexisting anomalies or
extreme prematurity thought to independently affect neurodevel-
opmental performance. Parents of the 27 eligible patients were
invited to participate in this study. Responses were obtained from
21 families, and neurodevelopmental testing was completed in 13.
Distance greater than 100 miles from the testing center was the
primary reason for nonresponse or noncompletion of testing. All
patients who had completed neurodevelopmental assessment by
September 2004 were included in this analysis.
Neurodevelopment Assessment
A comprehensive test battery was administered by a single devel-
opmental psychologist (CLB) under controlled conditions and with
institutional review board approval. Individual tests included in
this analysis were the McCarthy Scale of Children’s Abilities–
Motor and the McCarthy Scale of Children’s Abilities–General
Cognitive, the Beery Test of Visual-Motor Integration, and Achen-
bach’s Child Behavior Checklist. These 4 individual test scores
were normalized to an average score of 100 and standard deviation
(SD) of 15 and summed to generate a composite outcome score.
These tests measure a range of basic and higher-level integrative
motor, cognitive, and psychosocial skills, representing areas of
function that are at risk for impairment in children with complex
congenital heart disease.9,11,22,23 A cutoff of greater than 2 SD
The Journal of Thoracicfrom the population mean was used to classify test results as
abnormal.
Hemodynamic Assessment
Perioperative hemodynamic indices were recorded prospectively
for the first 48 hours after neonatal S1P, including arterial oxygen
saturation (SaO2), SVC SvO2, mean arterial blood pressure
(MABP), central venous pressure (CVP), heart rate (HR), hemo-
globin concentration, PaCO2, base excess, and pH and derived
parameters of arteriovenous oxygen saturation difference (Sa-vO2)
and arteriovenous oxygen content difference (Ca-vO2). Intraoper-
ative parameters included duration of support (DHCA time and
CPB time) and use of phenoxybenzamine.
Statistical Analysis
Data were expressed as means  SD for descriptive statistics and
as means  standard error for estimated statistics, with 95%
confidence intervals as appropriate. The differences in early he-
modynamic parameters between patients with normal or abnormal
outcomes were assessed by means of one-way analysis of variance
for mean values or by using the Fisher exact test for proportions.
The relationship between late outcome and early hemodynamic
parameters was assessed by means of multivariate, generalized,
least-squares (GLS) time-series regression with correction for au-
tocorrelation and by means of repeated-measures analysis of vari-
ance for nonlinear models. Continuous values for hemodynamic
parameters were divided into clinically appropriate strata to assess
the risk of abnormal outcome at key thresholds by means of
binomial odds ratios and time-series logistic regression. The cutoff
for significance was a P value of less than .05 after multiple
comparison correction with the Tukey honestly significant differ-
ence or the Bonferroni method when applicable. All calculations
were performed with Stata Version 8 (Stata Corporation, College
Station, Tex).
Results
Complete hemodynamic and outcome assessment was
available in 13 patients for this analysis. The cohort had S1P
at 7  8 days (median, 4 days) at a weight of 3.3  0.7 kg.
The duration of DHCA was 62  8 minutes, and the
duration of CPB was 128  50 minutes. The postoperative
hemodynamic profile was analyzed from a complete set of
624 hours of data. This profile showed a mean SaO2 of 77%
 5%, SvO2 of 52%  11%, Sa-vO2 of 25%  9%, hemo-
globin concentration of 15  1.5 g/100 mL, Ca-vO2 of 4.9
 1.8 mL/dL, MABP of 52  5 mm Hg, CVP of 11  3
mm Hg, HR of 168  18 min1, base excess of 3  4
mEq/L, and PaCO2 of 41  6 mm Hg. No patients required
postoperative mechanical circulatory support.
At the time of neurodevelopment assessment, patients
were 4.5  0.7 years of age and ambulatory after comple-
tion of the Fontan operation. The study population per-
formed below the population mean on a number of domains.
The McCarthy Scale of Children’s Abilities–Motor (42 
10 vs 50  10, P  .01), Beery Test of Visual-motor
Integration (87 14 vs 100 15, P .006), and composite
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Dscores (352  66 vs 400  60, P  .03) were significantly
below normal in the cohort. Five (38%; 95% confidence
interval, 14%-68%) patients had at least one clearly abnor-
mal score at least 2 SDs below the mean (Table 1).
The patients with any abnormal outcome (n  5) were
grouped to compare their early hemodynamic parameters
with those of patients without abnormal outcomes (n  8).
Univariate analysis of hemodynamics showed no significant
differences for MABP (51 5 vs 54 3 mm Hg, P .23),
SaO2 (78%  3% vs 74%  3%, P  .07), PaCO2 (41  3
vs 39  5 mm Hg, P  .36), DHCA time (60  6 vs 67 
12 minutes, P  .18), CPB time (118  21 vs 150  27
minutes, P  .33), or phenoxybenzamine administration
(8/8 vs 3/5, P  .14) between patients with normal and
abnormal outcomes. However, SvO2 was significantly lower
in patients with abnormal outcomes (56%  6% vs 46% 
8%, P  .024). Low SvO2 was present regardless of abnor-
mal outcome assessed (Table 2).
By treating each hour of hemodynamic data as a separate
independent “dose,” the additive risk of SvO2 on outcome
was assessed in a case-control model. Each hour at an SvO2
of 40% or less increased the risk of abnormal composite
outcome (risk ratio, 4.7; 95% confidence interval, 3.3-6.5; P
 .001). A clear dose-response effect was present for time
at progressively low SvO2 (Table 3).
TABLE 1. Summary of neurodevelopmental assessment in
the cohort and normal populations
Outcome Subject score Population score
No. (%)
abnormal P value
MSOCAG 90 27 100 15 3 (23%) .28
MSOCAM 42 10 50 10 1 (8%) .01
VMI 87 14 100 15 2 (15%) .006
CBCL 54 10 50 10 3 (23%) .18
Composite 352 66 400 50 4 (31%) .03
Values are presented as means  SD where shown. MSOCAG, McCarthy
Scale of Children’s Abilities–General Cognitive; MSOCAM, McCarthy Scale
of Children’s Abilities–Motor; VMI, Beery Test of Visual-Motor Integration;
CBCL, Achenbach’s Child Behavior Checklist.
TABLE 2. Postoperative SvO2 compared according to neuro
Outcome
No. of subjects
abnormal
SvO2 in s
with normal
MSOCAG 3 54
MSOCAM 1 54
VMI 2 54 
CBCL 2 54
Composite 4 55
Any 5 55 
Values are presented as means  standard deviation where shown. SvO
Abilities–General Cognitive; MSOCAM, McCarthy Scale of Children’s Abilitie
Behavior Checklist.
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patterns showed more subtle influences on late outcomes. In
this analysis systemic oxygen delivery, as measured on the
basis of SvO2, SaO2, and Sa-vO2, was significantly lower in
patients with abnormal outcomes (Figure 1). Borderline
differences were observed for PaCO2 and MABP (Figure 2).
There were no significant differences for hemoglobin con-
centration, HR, CVP, base excess, or pH (Table 4). Multi-
variable analysis revealed that the composite outcome score
was most powerfully related to circulatory arrest time of
greater than 60 minutes, SvO2, MABP, and PaCO2 in a model
that explained 79% of the variance in outcome (Table 5).
This multivariate predictive model demonstrated a signifi-
cant nonlinear relationship of SvO2 to all outcome measures,
with an apparent break point at an SvO2 of less than 40%.
The model of composite outcome score versus SvO2 is
shown in Figure 3. Multivariate modeling revealed signifi-
cant interaction between terms and nonlinear modulation of
the SvO2 effect by PaCO2 and prolonged DHCA time (Fig-
ures 4 and 5).
Discussion
The main conclusion of this analysis is that systemic oxygen
delivery, as assessed on the basis of SVC SvO2 in the early
postoperative period after the Norwood operation, was a
significant contributor to neurological function, as assessed
elopmental test result
ts
omes
SvO2 in subjects
with abnormal outcomes P value
45  11 .08
34 .014
39  9 .015
41  11 .041
45  9 .034
46  8 .024
temic venous oxygen saturation; MSOCAG, McCarthy Scale of Children’s
tor; VMI, Beery Test of Visual-Motor Integration; CBCL, Achenbach’s Child
TABLE 3. The number of hours spent at different SvO2
values and relative risk of abnormal composite outcome
SvO2 (%) Total (h) Cases (h) RR (95% CI)
Exact
P value
30% 23 14 8.5 (4.2-17.1) .001
31%-40% 67 28 5.8 (2.9-11.6) .001
41%-50% 153 15 1.4 (0.6-3.0) .523
50%-60% 255 30 1.6 (0.8-3.3) .21
60% 125 9 Reference
SvO2, Systemic venous oxygen saturation; RR, relative risk; CI, confidence
interval.dev
ubjec
outc
7
7
6
7
6
6
2, Sys
s–Moober 2005
2 2
arterial blood pressure; Hb, hemoglobin; CVP, central venous pressure; HR, hea
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Dat relatively late follow-up. In this population of children
treated at a single institution during a time of little variation
in intraoperative and postoperative management, 4 factors
(prolonged circulatory arrest time, SvO2, MABP, and PaCO2)
accounted for almost 80% of the variance in a composite
neurodevelopmental outcome score. Thus this study pro-
vides coherent data consistent with the hypothesis that peri-
operative systemic oxygen delivery can influence neurolog-
ical function significantly enough to affect long-term
development. Although a causal relationship is not proved
in this observational study, known pathophysiologic pro-
cesses link hypoxic-ischemic brain injury with neurodevel-
opmental delay, and thus management strategies that target
improved systemic oxygen delivery might not only improve
survival18,21 but likely also neurologic function.5,15,24
The strength of the association between factors related to
hypoxic injury and late outcome in this relatively small
study results partly from the wide range of performance and
frequency of poor performance observed in the subjects’
neurodevelopmental testing. The expected probability of 5
abnormal test results in this sample size would be no greater
than 1% if drawn from a normal sample. The possibility of
selection bias in subjects’ participation in neurodevelop-
h normal versus abnormal outcomes
Any abnormal outcome
(n  5) P value
46 3 (40-52) .012
75 1 (72-77) .036
29 2 (24-33) .039
5.6 0.5 (4.6-6.6) .086
0.08 0.05 (0-0.17) .14
7.45 0.01 (7.42-7.49) .17
39 2 (35-43) .17
54 2 (50-57) .18
14.3 0.5 (13.4-15.1) .45
10.5 1.2 (8.1-12.9) .67
168 5 (157-179) .89
re shown. SvO2, Systemic venous oxygen saturation; SaO2, arterial oxygen
nous oxygen content difference; POB, phenoxybenzamine; MABP, mean
TABLE 5. Multivariable regression on composite outcome
score
Variable Coefficient Variance P value Partial Correlation
DHCA (60 min) 99  28 26% .021 0.51
SvO2 5.0  1.6 22% .031 0.42
MABP 8.3 3.4 21% .031 0.38
PaCO2 8.8  4.4 10% .011 0.38
Model 79% .021
DHCA, Deep hypothermic circulatory arrest; SvO2, systemic venous oxygen
saturation; MABP, mean arterial blood pressure.Figure 1. Distributions of systemic venous oxygen saturation
(SvO2), arterial oxygen saturation (SaO2), and arteriovenous oxy-
gen saturation difference (Sa-vO2) over the first 48 postoperative
hours in the 2 subgroups of patients. Patients with abnormal
outcomes had lower systemic venous oxygen saturation (*P 
.012), arterial oxygen saturation (*P  .036), and higher arterio-
venous oxygen saturation difference (*P  .039) values.Figure 2. Forty-eight-hour distributions of arteriovenous oxygen
content difference (Ca-vO2), PaCO2, and mean arterial blood pres-
sure (MABP) were not different in patients with normal versus
abnormal outcomes.TABLE 4. Forty-eight-hour hemodynamic profile in patients wit
Parameter
Normal outcome
(n  8)
SvO2 (%) 55  2 (51-60)
SaO2 (%) 78  1 (76-80)
Sa-vO2 (%) 23  2 (19-26)
Ca-vO2 (mL/dL) 4.4  0.4 (3.6-5.2)
POB (mg · kg1 · d1) 0.17 0.04 (0.10-0.24)
pH 7.42 0.01 (7.39-7.45)
PaCO2 (mm Hg) 42  1 (39-45)
MABP (mm Hg) 51 1 (48-53)
Hb (g/dL) 14.7 0.4 (14.0-15.4)
CVP (mm Hg) 11.2 1.0 (9.2-13.0)
HR (1/min) 167 4 (159-176)
Values are presented as means  standard error (95% confidence interval) whe
saturation; Sa-vO , arteriovenous oxygen saturation difference; Ca-vO , arteriovert rate.
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Dmental assessment might contribute to the incidence of
abnormality, but this high incidence is consistent with other
reports.1,3,5,6,23 Although the absolute risk of abnormal out-
come could only be estimated by a prospective study with
complete ascertainment, the association between low post-
operative SvO2 and poor outcome is not likely to be influ-
enced by ascertainment bias in this sample population. The
perioperative demographic and hemodynamic profile of the
tested cohort was not different from that of the entire
contemporaneously operated S1P population (n  43, data
not shown).
The postoperative hemodynamic parameter most vari-
able in this patient population was SvO2, but the overall
hemodynamic profiles were otherwise distinctly unremark-
able. The children with poorer outcomes were specifically
not hypotensive, acidotic, or subject to extreme arterial
hypoxemia, conditions that have been associated with early
postoperative changes on magnetic resonance imaging.6,25
They received similar levels of inotropic support and had no
requirement for cardiopulmonary resuscitation. The results
of their management strategy simply failed to achieve the
target SvO2 for a greater period of time. Postoperative me-
chanical circulatory support was not used on an emergency
basis or electively to maintain organ perfusion.26
Because standard monitoring modalities did not discrim-
Figure 3. The composite outcome score was modeled as a func-
tion of hourly hemodynamic data and cardiopulmonary bypass
parameters (arterial oxygen saturation, systemic venous oxygen
saturation [SvO2], mean arterial blood pressure, central venous
pressure, PaCO2, cardiopulmonary bypass time, and deep hypo-
thermic circulatory arrest time). The model reveals the effect of
systemic venous oxygen saturation on outcome, with a break
point of a systemic venous oxygen saturation of less than 40% (*P
< .05, analysis of variance [ANOVA]). Adjustment for other pa-
rameters did not change the main model effect but increased the
power (from R2  0.49 to 0.63). CI, Confidence interval.inate patients with abnormal outcomes, we believe that
1098 The Journal of Thoracic and Cardiovascular Surgery ● Octmeasurements of organ oxygen economy by means of SvO2
or potentially NIRS should be used to characterize the
circulatory vulnerability in these patients and to guide ther-
apy. After S1P, patients are at high risk of inadequate organ
Figure 4. The interaction between prolonged deep hypothermic
circulatory arrest (DHCA) time and postoperative hemodynamics
is shown in a predictive model. Patients undergoing prolonged
deep hypothermic circulatory arrest had significantly lower com-
posite outcome scores at low systemic venous oxygen saturation
(SvO2; #P < .05, analysis of variance post-tests), and prolonged
deep hypothermic circulatory arrest reduced neurodevelopmental
outcome for any systemic venous oxygen saturation (*P < .05,
analysis of variance). Adjustment for other parameters did not
change the main or interaction model effects but increased the
power (from R2  0.49 to 0.58). CI, Confidence interval.
Figure 5. The interaction between postoperative PaCO2 and sys-
temic venous oxygen saturation (SvO2) is shown in a predictive
model. Patients with lower postoperative PaCO2 had poorer out-
come at lower systemic venous oxygen saturation compared with
that of patients with higher PaCO2 (*P< .05, analysis of variance).
Adjustment for other parameters did not change the main or
interaction model effects but increased the power (from R2 0.52
to 0.64). CI, Confidence interval.
ober 2005
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Doxygen delivery and low SvO2 because of the superimposi-
tion of low SaO2, low systemic blood flow, and increased
oxygen consumption.16,18 However, hypoxic-ischemic or-
gan injury can result from inadequate oxygen delivery from
a wide range of conditions, and we believe the relationship
between SvO2 and neurodevelopmental outcome is general-
izable to many high-risk populations.
In this relatively small sample, the effect of prolonged
DHCA was highly collinear with mild hypocapnia, such
that each term had univariate significance, but neither added
power to the multivariate model. This finding makes phys-
iologic sense in that prolonged DHCA causes prolonged
impairment in cerebrovascular resistance, such that oxygen
uptake and carbon dioxide production from the brain are
reduced after CPB.27 The data also support the speculation
that a hypercapnic management strategy might improve
cerebral blood flow after DHCA through reduction of cere-
brovascular resistance.17,28 The break point for poorer out-
come in our sample was DHCA time of greater than 60
minutes compared with the 45-minute break point from the
Boston Circulatory Arrest Study.9 Our CPB strategy main-
tained a higher PCO2 and hemoglobin concentration than that
in the Boston Circulatory Arrest Study analysis. Strategies
that include a higher hemoglobin concentration10 and a
higher PaCO211 have been shown to improve outcome from
DHCA, and thus our data are consistent with a variable
dose-dependent injury related to DHCA,9,22,29 which can be
affected by parameters related to cerebral oxygen delivery,
such as PaCO2 and hemoglobin concentration.
In patients with parallel circulation, reduction in sys-
temic vascular resistance can improve systemic flow by
reducing and stabilizing the pulmonary/systemic flow ra-
tio.30,31 In patients with limited cardiac output, reduction in
systemic vascular resistance might divert blood flow away
from the cerebral circulation.17,32 Theoretic objections to
the use of afterload reduction in this patient population stem
partly from this concern.33 In this study we found no evi-
dence that the use of phenoxybenzamine impaired neuro-
logic outcome.
The postoperative parameter most strongly related to
outcome was SvO2. Because SvO2 is the flow-weighted
average of regional venous saturations and because the
cerebral blood contributes significantly to SVC venous
blood in the resting and sedated patient, SvO2 will be
strongly influenced by cerebral oxygen economy.15,34 The
SvO2 might thus be closely related to whole-brain oxygen
saturation in this analysis, and other measures of brain
oxygen status, such as NIRS, might more directly reflect
conditions of cerebral hypoxia related to adverse
outcome.15,24,35,36
The hemodynamic vulnerability detected by decreased
postoperative SvO2 reflects impaired oxygen delivery to
metabolism balance. This impairment of oxygen economy
The Journal of Thoracicin the early postoperative period was related to later neuro-
cognitive disability, presumably through the development
of hypoxic brain injury. Although low SvO2 tended to im-
prove over the first 48 postoperative hours, the underlying
circulatory vulnerability might persist, and those patients
demonstrating late outcome impairment might have recur-
rent hypoxic injury beyond the acute perioperative period.5
Strategies to improve SvO2 and brain oxygenation in the
perioperative period and beyond are likely to reduce the
occurrence of hypoxic brain injury in high-risk patient
populations.
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